Emerging Trends In Bioabsorbable Vascular Scaffolds
Dr. Bruce Anneaux, former Corporate Director of Research at Zeus Industrial Products, and Dr. James Oberhauser, Medical Device Consultant, discuss trends in bioabsorbable vascular scaffolds for the treatment of coronary artery disease.
Coronary artery disease (CAD) is the most common type of heart disease and the leading cause of death in adults. Bioabsorbable vascular scaffolds (BVS) offer new technology options to treat CAD and other diseases of the vasculature. These devices can be used to reinforce and maintain patency of diseased vessels during the healing and remodeling process and are then safely absorbed by the body.
Challenges And Advances In Polymer Technology To Treat CAD
Continuing discoveries in polymer science have led to the development of implantable products that can be absorbed while in the body. Developments like these must also be coupled with manufacturing considerations to truly bring a new product to reality. While the transition from permanent metallic stents to bioabsorbable polymers has been slow and challenging, their advantages are many and consequential. Join us for this webinar where we discuss why treating CAD with BVS is considered to be the “next revolution” in endovascular therapy.
Zeus’ history and reputation of partnering with manufacturers and research and development groups is long well-recognized. Today, companies – whether well-established or start-up – know that when they come to us, we deliver!